retatrutide dosing clinical trial retatrutide dose Guide: 1-12 mg Weekly Triple Agonist (2026) Is Retatrutide Too Strong? What

Tirzepatide works by targeting the dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist, making it the first weight loss and diabetes care medication that targets 2 receptor agonists

Your provider should assess whether GLP-1 fits your overall treatment landscape and baseline clinical status

doi: 10.1007/s00125-022-05715-4 56 European Medicines Agency

While beneficial effects are observed when compounds trigger bias at the GLP-1R towards G protein signalling ( Genetic variation at the incretin receptors The most direct answer to why people fail to respond to incretin therapies is that they might express non-functional incretin receptors

NIH, National Institutes of Health

Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, et al